Investigating Novel Strategies in Pediatric Immune Responses and Microbiome Environment: Comprehensive Lung Disease Investigation in Children. (INSPIRE CHILD)

Aarhus University Hospital

Status: Invitation-only

Conditions: Lung Diseases

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT06746077

VEK j.nr. 1-10-72-8-24

Details and patient eligibility

About

The INSPIRE CHILD-study is a clinical research project focused on understanding lung diseases in children. The study aims to explore how the presence of certain bacteria, immune responses, and inflammatory markers in the lungs are connected to different lung diseases in pediatric patients.

Background:

Lung diseases in children can have long-lasting effects on their health, not only during childhood but also as they grow into adults. However, the specific causes and mechanisms behind these diseases are not yet fully understood. The INSPIRE CHILD-study is designed to investigate whether children with various lung conditions have distinct differences in the types of bacteria, immune system activity, and inflammation in their lungs.

Hypothesis:

Different lung diseases in children are hypothesized to be associated with unique patterns of bacteria, immune responses, and inflammation in the lungs By studying these patterns, the investigators hope to gain new insights that could lead to better diagnostic tools and more personalized treatments for children suffering from lung diseases.

Children already scheduled to undergo bronchoscopy are included in the study. A small sample of fluid from the lungs is collected, and the sample is analyzed for bacteria, immune markers, and signs of inflammation. This research could pave the way for improved care and treatment for young patients with lung conditions.

Enrollment: 200 estimated patients

Sex: All

Ages: Under 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ranging from new-born to 17 years of age.
• Diagnosed with or being assessed for a lung disease.
• Possible to sample at least 2 ml of BAL-fluid besides the scheduled amount during the bronchoscopy.

Exclusion criteria

• Age older than 17 years.
• Not undergoing diagnosis at Childrens Center for Pulmonary and Allergic diseases.
• Failure to meet the requirement of being able to sample an additional 2 ml of BAL-fluid.